SOX5 and glioblastoma: Another promising target is the NEAT1/miR-181d-5p/SOX5 axis that regulates the permeability of BTB in GECs, since the selective increase of BTB permeability and more efficient drug delivery are some of the ultimate challenges in the chemotherapeutic treatment of GBM.